๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

15 recruiting trials

for Retinitis Pigmentosa (RP)

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa NCT06628947Phase 25 sites๐Ÿ“ Sydney๐Ÿ“ Woolloongabba๐Ÿ“ Adelaide Kiora Pharmaceuticals, Inc. ยท Tests: Placebo (Sterile Saline or Balanced Salt Solution), 100 ฮผg KIO-301, 50 ฮผg KIO-301 Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital NCT07292987NA1 site๐Ÿ“ Paris Centre Hospitalier National d'Ophtalmologie des Quinze-Vingโ€ฆ ยท Tests: Enhanced post-diagnostic support, Usual Care A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome NCT07710196Phase 31 site๐Ÿ“ Dallas Nacuity Pharmaceuticals, Inc. ยท Tests: Placebo, NPI-001 A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa NCT06891885Phase 1, Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Minneapolis Sumitomo Pharma America, Inc. ยท Tests: DSP-3077 Retinal Sheet Cohort 1, DSP-3077 Retinal Sheet Cohort 2, DSP-3077 Retinal Sheet Cohort 3 Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients NCT06292650EARLY Phase 11 site๐Ÿ“ Beijing Zhongmou Therapeutics ยท Tests: ZM-02-L, ZM-02-H, ZM-02-S Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies NCT06787482Phase 1, Phase 22 sites๐Ÿ“ Cairo๐Ÿ“ Giza Ace Cells Lab Limited ยท Tests: ACE Retino A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) NCT07408232Phase 1, Phase 22 sites๐Ÿ“ Portland๐Ÿ“ Dallas Octant, Inc. ยท Tests: Phase 1b/2: Cohort 1 - OCT-980 Tablet, Phase 1b/2: Cohort 2 - OCT-980 Tablet, Phase 1b/2: Cohort 3 - OCT-980 Tablet, Phโ€ฆ Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa NCT07774975Phase 11 site๐Ÿ“ Fukuoka Kyushu University ยท Tests: ULREA-PVS-NP A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) NCT06789445Phase 1, Phase 25 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Philadelphia BlueRock Therapeutics ยท Tests: OpCT-001, OpCT-001 Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment NCT07341763NA1 site๐Ÿ“ Waterloo University of Waterloo ยท Tests: Active hf-tRNS., Placebo/sham hf-tRNS Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance NCT07548944n/a1 site๐Ÿ“ Frankfurt am Main Okuvision GmbH ยท Tests: Transcorneal Electrical Stimulation using the OkuStim System Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy NCT07807111Phase 1, Phase 23 sites๐Ÿ“ Ghent๐Ÿ“ Paris๐Ÿ“ Dublin SparingVision ยท Tests: SPVN20 (high dose), SPVN20 (medium dose), SPVN20 (low dose) Natural History Study of Patients With EYS-Associated RP NCT07228793n/a1 site๐Ÿ“ Moscow Sensor Technology for Deafblind ยท Tests: Whole exome/genome sequencing Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration NCT07266584NA1 site๐Ÿ“ Sydney Science Corporation ยท Tests: PRIMA Products Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients NCT07126470NA3 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen๐Ÿ“ Wuhan Zhongshan Ophthalmic Center, Sun Yat-sen University ยท Tests: CTR implantation
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy